SINOPHARM (01099): China National Accord Medicines Corporation (000028.SZ) expects the net profit attributable to the parent in 2025 to be approximately 10.55 billion to 12.15 billion yuan, a year-on-year increase of 64.20% to 89.11%.

China National Pharmaceutical Group (01099) announced that it is expected that China National Pharmaceutical Group (000028.SZ) will achieve a net profit attributable to the shareholders of the listed company of 10.55 billion to 12.15 billion yuan in 2025, a year-on-year increase of 64.20% to 89.11%. It is expected that the net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses will be 9.96 billion to 11.56 billion yuan in 2025, a year-on-year increase of 71.38% to 98.91%.